The Tumor Hacker: How Data & AI Are Rewriting the Future of Oncology

Inside the conversation

Professor Olivier Michielin, Head of Precision Oncology at Geneva University Hospitals (HUG), joins Dr. Jurgi Camblong for a conversation about how physics, data, artificial intelligence and immunotherapy are changing cancer research and care.

The episode explores how data-driven approaches can support clinicians, combine biological and clinical evidence, and advance precision oncology — themes at the heart of NAIPO’s mission.